LP
Lucid Peptides
Research Grade

Research Summary

Selank

Research Hub
Clinical — 10 studies

Selank is a synthetic heptapeptide studied for its anxiolytic and neuroregulatory properties without sedative effects.

Being studied for

Anxiety-related cognitive researchNeurotransmitter regulationStress adaptation mechanisms

Published Research

Evidence profile

Controlled human evidence

10 cited publications · 1 primary trial

Findings below belong to the studies that reported them. They describe the material and conditions those authors used, not this product, and not an outcome to expect.

Supporting evidence

ClinicalPrimary trial

[A comparison of the anxiolytic effect and tolerability of selank and phenazepam in the treatment of anxiety disorders]

Medvedev VE et al. · Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova · 2014

The study reportedConclusion. The data obtained in the study extend therapeutic possibilities in the treatment of anxiety disorders.

PMID 25176261
View on PubMed
Additional indexed literature (9)

Published studies summarised here concern the specific investigational or pharmaceutical materials and study conditions described by their authors. Their findings are not performance claims for Lucid Peptides material. Citations verified against PubMed on 2026-08-09.

View full peptide profile for Selank
All Research
[Notice]All information on this page is provided strictly for laboratory research and educational purposes only.